由药融圈&Synbio深波联合发起，药融圈产业研究院精心编纂的 《2025中国合成生物制造产业发 展白皮书》 （以下简称《研究报告》），已于8月1日 在Synbio China 第三届中国合成生物学"科 学家+企业家+投资家"博览会正式发布！ 本白皮书介绍了生物制造的发展现状及趋势，分析了生物制造的产业链和重点应用方向， 并精选 出中国生物制造产业10大链主企业，整理了15家上市公司合成生物学布局方向以及20大热门品种 ，同时探讨了生物制造面临的挑战，最终提出了针对性的政策建议，供业内参考 。 领取方式： 关注本公众号，扫码添加下方微信获取 添加请备注：单位+职位+姓名 封面一览 Synthetic Biology 深波 1 251 息息与人脉精准链接平台 2025中国合成生物 制造产业发展白皮书 近年来，生物制造的热度居高不下，作为新兴的战略性领域，生物制造因其创新性和对传 统生产方式的颠覆性，被视为新的增长点，有助于推动产业结构优化和经济模式的转变。 China's synthetic biomanufacturing industry Development White Paper 目录 一、 凯赛生物 ...

声明： 因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文由仅作新材料相关领域介绍，本文不构成任何投资建议！转载请注明来源！ 近日， 珠海麦得发生物科技股份有限公司 （以下简称"麦得发"）宣布完成B轮融资，本轮融资由中国太平创新、广药资本联合注资。 据资料显示，随着合成生物学技术持续突破与生产成本逐步下降，PHA产能预计将快速提升，到2029年全球产能有望接近100万吨，约占生物降解塑料总 产能的四分之一，成为高端医疗、特种包装等场景的核心替代材料。 2026年3月31日-4月1日， " 第五届中国合成生物学及生物制造大会 " 将 在 杭州 隆重举行，其中设置 【 生物基化学品与材料专场 】 ，诚邀各位专家及相关从业者 参会交流！ 本次融资资金将 主要用于 PHA（聚羟基脂肪酸酯） 上下游管线持续研发生产、全球市场拓展及核心团队升级建设 。 据悉，麦得发成立于2019年，专注于研究、开发、生产及商业化最新一代纯生物基全域降解材料PHA及其高值健康小分子，并积极探索其在绿色健康、 医疗健康和营养健康等前沿领域的创新应用。 作为聚焦新一代纯生物基全域降解材料的创新企业，麦得发凭借自主知识产权的菌种构 ...

Core Insights - The article emphasizes the importance of bio-based chemicals and materials as a key pillar of the bio-manufacturing industry, highlighting their advantages such as renewable raw materials and low carbon emissions throughout their lifecycle, which positions them to replace traditional petroleum-based products in various sectors like packaging, textiles, and automotive [2] - The Chinese government prioritizes the development of bio-based new materials, categorizing them as strategic materials, and has implemented multiple supportive policies for the industry. However, challenges remain, including cost competitiveness, stability of raw material supply chains, product performance optimization, and market acceptance [2] Event Details - The "5th China Synthetic Biology and Bio-Manufacturing Conference" will be held in Hangzhou from March 31 to April 1, 2026, with an expected attendance of 1,000 participants [4] - The conference aims to gather insights from various sectors including industry, academia, and research to address challenges in the bio-based chemicals and materials industry and promote high-quality development [2][4] Forum Setup - The conference will feature multiple sessions, including: - Day 1 AM: Bio-Manufacturing Industry Ecological Conference and Life China Third Functional Food and Nutrition Science Conference - Day 1 PM: Special sessions on food and drug synergy, efficacy skincare, and AI + bio-manufacturing - Day 2 AM: Special sessions on functional raw materials and bio-manufacturing, and bio-manufacturing processes - Day 2 PM: Special sessions on future food and all-age nutrition, and bio-based chemicals and materials [8] Proposed Topics - Topics to be discussed include: - Green bio-manufacturing of bio-based bulk chemicals - Molecular and material innovation based on synthetic biology technology - Large-scale production and high-value utilization of bio-based platform compounds - Development and application of furan bio-based new materials technology - Industrialization practices for high-value utilization of non-food biomass [13]

Core Insights - The article emphasizes the importance of bio-based chemicals and materials as a key pillar of the bio-manufacturing industry, highlighting their advantages such as renewable raw materials and low carbon emissions throughout their lifecycle, which positions them to replace traditional petroleum-based products in various sectors like packaging, textiles, and automotive [2] - The Chinese government prioritizes the development of bio-based new materials, categorizing them as strategic materials, and has implemented multiple supportive policies for the industry. However, challenges remain, including cost competitiveness, stability of raw material supply chains, product performance optimization, and market acceptance [2] Event Details - The "5th China Synthetic Biology and Bio-Manufacturing Conference" will be held in Hangzhou from March 31 to April 1, 2026, with an expected attendance of 1,000 participants [4] - The conference aims to gather insights from various sectors including industry, academia, and research to address challenges in the bio-based chemicals and materials industry and promote high-quality development [2][4] Forum Structure - The conference will feature multiple sessions, including: - Day 1 AM: Bio-Manufacturing Industry Ecosystem Conference and Life China Third Functional Food and Nutrition Science Conference [8] - Day 1 PM: Special sessions on food and drug synergy, efficacy skincare, and AI + bio-manufacturing [8] - Day 2 AM: Special sessions on functional raw materials and bio-manufacturing, and bio-manufacturing processes [8] - Day 2 PM: Special sessions on future food and all-age nutrition, and bio-based chemicals and materials [8] Proposed Topics - Topics to be discussed include: - Green bio-manufacturing of bio-based bulk chemicals - Molecular and material innovations based on synthetic biology technology - Large-scale production and high-value utilization of bio-based platform compounds - Development and application of furan bio-based new materials technology - Industrialization practices for high-value utilization of non-food biomass [13]

Group 1 - The core project of Zhongke Kangyuan is the "Straw Synthesis Biological Conversion Project," which has officially settled in Baoying County, Jiangsu, with a total planned capacity of 600,000 tons and a total investment of 1 billion yuan [3]. - The first phase of the project will cover approximately 60 acres, with a new factory building of 30,000 square meters and an equipment investment of 80 million yuan, aiming to establish a production line for 150,000 tons of straw biological conversion feed, expected to generate annual sales exceeding 300 million yuan and tax revenue exceeding 8 million yuan [3]. - The second phase plans to invest in a production line for 200,000 tons of straw saccharification single-cell protein feed [3]. Group 2 - Zhongke Kangyuan (Tangshan) Biotechnology Co., Ltd. was founded by Dr. Zhang Dongyuan, a researcher from the Tianjin Institute of the Chinese Academy of Sciences and a recipient of the National "Ten Thousand Talents Program," focusing on the research and development of biomass depolymerization molecular chemical processes [4]. - The company has established two provincial-level R&D platforms and one Chinese Academy of Sciences achievement transformation base, with a production base of 200,000 tons, and its products are applied in livestock breeding and large-scale fermentation production as corn substitutes [4]. - Zhongke Kangyuan has led 14 research projects, including participation in three national key R&D projects, and has obtained 36 national intellectual property patents related to biomass depolymerization molecular technology [4].

Core Viewpoint - The article highlights the successful completion of nearly 100 million RMB in Series B financing for Jinghai Weixiang Biotech Co., Ltd., which will enhance the company's technological advancements, production capacity, and market expansion in the biobased materials sector [1][3]. Group 1: Financing and Growth - The Series B financing was exclusively invested by Jiazhih Fund, with Kaicheng Capital serving as the advisor and continuing to assist in subsequent fundraising efforts [1]. - The funds will primarily be used for expanding the production capacity of the company's scale-up production base, iterative research and development of next-generation technologies, and market channel expansion [3]. - The company has achieved significant milestones in the industrialization of biobased materials, with steady increases in production capacity and market share, and this financing will further accelerate its growth process and solidify its industry-leading position [3]. Group 2: Technological Advancements - Jinghai Weixiang has developed several internationally leading production technologies for the entire biobased materials industry chain, focusing on key breakthroughs such as "non-grain biomass utilization," "next-generation industrial strains," "gypsum-free lactic acid technology," and "rPLA recycling" [2]. - The "gypsum-free lactic acid technology" addresses the environmental pollution caused by gypsum waste in traditional lactic acid production, enabling cleaner and lower-cost production [2]. - The "rPLA recycling" process not only allows for the recycling of polylactic acid (PLA) but also effectively reduces production costs, contributing to a sustainable development cycle for biobased materials [2]. Group 3: Product and Market Applications - The core product, polylactic acid (PLA), is a high-performance biodegradable material with excellent biocompatibility, degradability, and processing capabilities, widely used in various sectors including fast-moving consumer goods, food and beverage, agriculture, 3D printing, textiles, biomedicine, and high-end manufacturing [2]. - With its comprehensive industry chain layout, Jinghai Weixiang can control the entire process from raw material supply to biobased material production and recycling, ensuring product quality stability and providing significant cost advantages and market competitiveness [2].

Group 1 - The article emphasizes the strategic importance of biological manufacturing as a key industry for future development, highlighted by its inclusion in the 15th Five-Year Plan alongside quantum technology and 6G [2] - The upcoming "SynBio China Fourth Synthetic Biology and Biomanufacturing Conference" will take place in Shenzhen on January 8-9, 2026, focusing on industrialization technology challenges and providing comprehensive solutions for intelligent manufacturing and green production [3][2] - The conference aims to gather experts from academia and industry to analyze the entire process of "design-build-test-learn" in synthetic biology, addressing the optimization and innovation opportunities in various industrialization stages [2] Group 2 - The conference is expected to host around 1,000 participants, indicating significant interest and engagement in the field of synthetic biology and biomanufacturing [3] - There are opportunities for exhibitors from synthetic biology and modern biotechnology sectors to showcase their products and technologies at the conference [9] - Registration for the conference is currently free but limited, emphasizing the need for early registration to secure participation [12]

Group 1 - The project of Inner Mongolia Zhongke Kelan New Materials Technology Co., Ltd. for producing 33,000 tons of fully biodegradable materials (PDA) has reached a significant milestone with the completion of the main structure and the arrival of the first batch of production equipment [2][3] - The PDA project is divided into two phases, with Phase 1 aiming to establish a production capacity of 3,000 tons and Phase 2 targeting an additional 30,000 tons [2][3] - The project is expected to start equipment installation by the end of November and achieve continuous production of 3,000 tons of PDA by June 2026, with Phase 2 preparations already underway [3] Group 2 - PDA, developed by Beijing Zhongke Kelan New Materials Technology Co., Ltd., is designed to fully degrade in various natural environments without leaving microplastic residues, aligning with national green development strategies [3] - The stable supply of BDO (1,4-butanediol), with a current production capacity of 1.6 million tons in Wuhai, is crucial for the large-scale production of PDA [3] - Zhongke Kelan's PDA products are tailored for four major fields: electronic information, ecological agriculture, marine applications, and innovative applications, and have been successfully applied by several Fortune 500 companies [4]

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field that disrupts traditional production methods, presenting it as a new growth point for optimizing industrial structure and transforming economic models. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper outlines the development status and trends of biomanufacturing, analyzing the global landscape and key platform facilities [5]. - It compares the biomanufacturing sectors of China and the United States, identifying competitive advantages and areas for improvement [5]. - Future development trends in biomanufacturing are discussed, indicating a shift towards more integrated and sustainable practices [5]. Group 2: Policy Landscape - The report details major policies affecting biomanufacturing in both domestic and international contexts, providing insights into regulatory frameworks that shape the industry [5]. - It highlights the importance of supportive policies for fostering innovation and growth in the biomanufacturing sector [5]. Group 3: Industry Map and Applications - The white paper presents a comprehensive map of the Chinese biomanufacturing industry, identifying key players and their roles [5]. - It analyzes the biomanufacturing industry chain and key application areas, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5]. Group 4: Key Enterprises and Investment Landscape - The report identifies ten leading enterprises in the Chinese biomanufacturing sector, showcasing their contributions and market positions [6]. - It summarizes the strategic directions of 15 listed companies in synthetic biology, highlighting their investment and development strategies [6]. - The investment landscape for synthetic biology in China is examined, providing data on funding trends and opportunities [6]. Group 5: Challenges and Recommendations - The white paper discusses the challenges faced by the biomanufacturing industry in China, including technological, regulatory, and market barriers [6]. - It offers targeted policy recommendations to address these challenges and promote sustainable growth in the biomanufacturing sector [6].

Core Insights - The article highlights the upcoming "SynBio China Fourth China Synthetic Biology and Biomanufacturing Conference" scheduled for January 8-9, 2026, in Shenzhen, emphasizing the importance of biomanufacturing in future industries [4][8]. Group 1: Conference Details - The conference will feature Dr. Zhang Dongyuan, Chairman of Zhongke Kangyuan (Tangshan) Biotechnology Co., Ltd., who will present a report on the key technologies for the depolymerization of non-grain biomass [2][4]. - The event aims to gather 1,000 participants from various sectors, including academia and industry, to address challenges in industrialization technology [8]. Group 2: Background and Significance - The conference is positioned within the context of China's strategic focus on biomanufacturing as a critical area for future development, alongside quantum technology and 6G [7]. - The article discusses the challenges of crossing the "valley of death" in biomanufacturing, highlighting opportunities for optimization and innovation in various industrialization processes [7]. Group 3: Technological Innovations - Zhongke Kangyuan has developed a comprehensive technology system for biomass depolymerization over seven years, including key technologies such as a continuous oxidation depolymerization system and a high-solid continuous fermentation system [4]. - The company has successfully established China's first production line capable of processing 200,000 tons of straw protein and digestible sugars [4].